Author response for "Pharmacokinetic and pharmacodynamic equivalence of Biocon's biosimilar Insulin N with <scp>US</scp> ‐licensed Humulin® N formulation in healthy subjects: Results from the <scp>RHINE</scp> ‐2 (Recombinant Human <scp>INsulin</scp> Equivalence‐2) study"
crossref（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要